Resources
organoid service platforms
Developing platforms or centers that create organoids on demand allow researchers to study biology closer to physiological conditions and it contributes toward personalized medicine.
Resources
Developing platforms or centers that create organoids on demand allow researchers to study biology closer to physiological conditions and it contributes toward personalized medicine.
Understanding of mammalian biology at the tissue level and studying organ development and how they change during disease state in humans has been difficult due to ethical concerns and inaccessibility of sample. Conventional monolayer cell cultures, derived from human tissue have been used for decades to create experimental tools to study basic and cancer biology. Unfortunately, these cell lines are transformed and acquire irrelevant mutations overtime that do not reflect the biological characteristics of the tissue of origin. Moreover, these cultures are two-dimensional and do not mimic the tissue architecture and the cellular heterogeneity present in the tissue or the tumor of origin. An alternative to model cancer has been to put human tumors growing into mice creating ‘’patient-derived xenograft’’ but the absence of the immune system in these models and the cross-species difference between human tumor cells and the mouse environment has limitation in the interpretation of the results. Furthermore, these models are expensive and time-consuming.
Advances in developmental and stem cell biology has allowed to decipher the growth factors and signaling pathways necessary for a stem cell to receive proper environmental conditions to differentiate and arrange themselves to form a structure with similar characteristics of the tissue of origin in vitro. These three-dimensional (3D) structures called ‘’organoids’’ display similar functional properties of the tissue of origin including the genetic and the cellular heterogeneity, making them highly valuable tools to study tissue homeostasis and tumorigenesis.
Developing platforms or centers that create organoids on demand allow researchers to study biology closer to physiological conditions and it contributes toward personalized medicine. These platforms represent a first-in-class physiological platform for research on living disease tissue.
ANTICIPE laboratory (France)
Predictive tumoroid platform
This platform is localized in Caen at the ANTICIPE laboratory and is directed by Dr. Laurent Poulain and Dr. Louis-Bastien Weiswald. ORGAPRED produces organoid derived from ovarian cancers, also called ‘’tumoroid’’. The aim of the platform is to use tumor organoids for research and predicting response to treatment. One of their final goals is to characterize non-responsive patients within few weeks.
Canther laboratory (France)
Specialized in therapeutic resistance
This platform is localized in Lille at the Canther laboratory and directed by Dr. Audrey Vincent. The platform is specialized in gastro-esophageal, pancreas, colon cancer and is specialized in therapeutic resistance.
PrEclinical and TRAnslational Neuro-Oncology Research Network (France)
PETRA »TECH » platform
PETRA »TECH » is the technical platform of the PETRA network which aims to structure neuro-oncology in the South Region (Action structurante Canceropôle PACA 2023).
This platform is specialized in preclinical models of brain tumors and is localized on 2 sites, in Marseille for the study of the tumor microenvironment (scientific manager: Dr. Aurélie Tchoghandjian), and in Nice for the study of cancer stem cells (scientific manager: Dr. Thierry Virolle). Both sites offer their respective expertise in 3D human preclinical models (explants, spheroids, tumoroids, organoids, organotypic cultures) and animal models (xenografts, syngeneic models, tumor resection models), with the aim to translate as fast as possible the results from bench to patients’ bedside.
Institute for Research on Cancer and Aging (France)
Screening platform in cancerology
In drug discovery programs, multicellular spheroids have emerged as powerful tools to bridge the gap between in vitro cell culture models and in vivo tissues. 3D tumor cultures are a promising tool for in vitro rebuilding the in vivo behaviour of cancer cells for the development and validation of anti-tumor therapies.
Yet, in vitro models capable to realistically mimic the complex ecosystem of solid tumors is an unmet need. In solid cancer mutual interactions between the epithelial transformed cancer cells and their surrounding partners, (including stromal non-transformed cells; carcinoma-associated fibroblasts, endothelial cells, adipocytes, pericytes, innate and adaptive immune cells) embedded within a complex extracellular matrix (ECM), favour tumor development, metastatic spreading and resistance to chemotherapeutic treatments. Therefore, the development of 3D multicellular spheroids embedded in a collagen rich matrix in vitro would significantly improve the early phase of drug discovery in preclinical cancer research.
The 3D-Hub-S platform is localized in Nice at the IRCAN and is directed by Dr. Gaggioli. The 3D-Hub-S platform can perform drugs screening for novel anti-cancer therapies
Cincinnati’s Children (United States)
Platform for drug screening and personalized regenerative medicine.
The CuSTOM platform is localized in Cincinnati, OHIO, USA at the Cincinnati Children’s Hospital and is directed by Dr. Aaron Zorn and Dr. James Wells.
Specialized in organoids made from induced pluripotent stem cells (iPSC), this platform establishes GI organoids (esophagus, fundus, antrum, duodenum and colon) and pancreatic organoids and thereby offers possibilities for accelerating discovery and facilitating bench-to-bedside translation of organoid technology.
LIST YOUR PLATFORM
The 3D-Hub-O website was created on an independent initiative, publications reflect only the views of the project owner.
Email : organoide.3d-hub-o@inserm.fr
Centre de Recherche en Cancérologie de Marseille
27 bd Lei Roure
13273 Marseille cedex 09
Scientific manager: Géraldine GUASCH
Technical manager: Véronique CHEVRIER
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyParamètresNous pouvons demander que les cookies soient réglés sur votre appareil. Nous utilisons des cookies pour nous faire savoir quand vous visitez nos sites Web, comment vous interagissez avec nous, pour enrichir votre expérience utilisateur, et pour personnaliser votre relation avec notre site Web.
Cliquez sur les différentes rubriques de la catégorie pour en savoir plus. Vous pouvez également modifier certaines de vos préférences. Notez que le blocage de certains types de cookies peut avoir une incidence sur votre expérience sur nos sites Web et les services que nous sommes en mesure d'offrir.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
Vous pouvez lire plus sur nos cookies et les paramètres de confidentialité en détail sur notre Page de Politique de Confidentialité.
Politique de confidentialité